A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy - Related Studies

A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

This study has been completed.

Study NCT00002085. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Communicable Diseases
		Infection
		Mycobacterium avium-intracellulare Infection
		Mycobacterium Infections
		Tuberculosis

3	More general conditions related to this trial
		Actinomycetales Infections
		Bacterial Infections
		Gram-Positive Bacterial Infections
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Mycobacterium Infections, Atypical
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Azithromycin

5	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Pfizer